DCIS Dilemmas

Women often think that their risk of getting Ductal Carcinoma In Situ (DCIS) or Invasive Breast Cancer (IBC) is much higher than real numbers show. This fear is often fed by new stories about research, and sometimes by their own doctors. Many doctors and researchers say that DCIS is not Invasive Breast Cancer (IBC) because it stays in the breast duct. HOWEVER... DCIS is also called Stage 0 breast cancer, and is treated as if it were IBC. There are many dilemmas about DCIS, and this book tries to clear them up. We know how easy it is to end up more confused after looking at different websites, books, and research results. We present a new way to approach DCIS that combines the latest research with practical information. Even though we state things plainly, many scientific resources and references were used to make sure this book is accurate. Please be aware that those resources may use older language that we are learning is not accurate for DCIS. For example, DCIS lesions do not have the ability to 'recur,' even though this term is commonly used by many scientists and doctors. You will learn about DCIS and how it fits into breast diseases, including breast cancer. The process of getting diagnosed is also explained, as are the different types of treatments that are commonly given for DCIS. Risks are also explained clearly. This includes the risk of being diagnosed with DCIS, as well as the risk of getting another DCIS or a future Invasive Breast Cancer. This book also highlights the various kinds of ongoing research for DCIS. A list of terms, and additional resources and references are also included to help you find more detailed information. We hope this book offers useful information to help you make decisions about DCIS, and look forward to hearing how you use it!'Bravo! A comprehensive, easy to read and much needed discussion about DCIS! A must read for breast cancer advocates, clinicians and those diagnosed with DCIS. It is a treasure trove of scientifically documented and resourced information. Spot on discussion about understanding 'risk' (pages 34-36). Thank you for creating this very timely resource.'Cheryl Jernigan, Breast cancer survivor/patient research advocate, Susan G. Komen Advocate in Science